3 Big Advantages Novavax Has Over Moderna

3 Big Advantages Novavax Has Over Moderna

Source: 
Motley Fool
snippet: 

Novavax (NASDAQ:NVAX) has yet to begin its anticipated U.S. late-stage study of its COVID-19 vaccine candidate. But if you're thinking that this puts Moderna and Novavax in completely different leagues, think again. Actually, there are three big advantages that Novavax has over Moderna.